Utah Medical Products, Inc. (UTMD)

NASDAQ: UTMD · Real-Time Price · USD

Compare

62.58

+0.94 (1.52%)

At close: Feb 9, 2026, 4:00 PM EST

62.39

-0.19 (-0.30%)

After-hours: Feb 9, 2026, 4:00 PM EST

Utah Medical Products Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	38.52	40.9	50.22	52.28	49.05
Revenue Growth (YoY)	-5.83%	-18.56%	-3.94%	6.58%	16.30%
Cost of Revenue	16.52	16.76	20.19	20.09	18.14
Gross Profit	22	24.14	30.04	32.2	30.92
Selling, General & Admin	9.93	7.6	11.04	11.91	11.51
Research & Development	0.67	0.81	0.56	0.49	0.53
Operating Expenses	10.6	8.41	11.6	12.41	12.04
Operating Income	11.4	15.73	18.44	19.79	18.88
Interest & Investment Income	-	3.37	3.04	0.66	0.17
Currency Exchange Gain (Loss)	-0.02	0	-0.01	-	-
Other Non Operating Income (Expenses)	2.73	-0.16	0.28	0.21	0.02
EBT Excluding Unusual Items	14.11	18.94	21.75	20.66	19.06
Legal Settlements	-	-2.14	-1.66	-	-
Pretax Income	14.11	16.8	20.09	20.66	19.06
Income Tax Expense	2.82	2.93	3.45	4.19	4.27
Net Income	11.29	13.87	16.64	16.47	14.79
Net Income to Common	11.29	13.87	16.64	16.47	14.79
Net Income Growth	-18.65%	-16.60%	0.98%	11.39%	36.95%
Shares Outstanding (Basic)	3	4	4	4	4
Shares Outstanding (Diluted)	3	4	4	4	4
Shares Change (YoY)	-7.51%	-3.68%	-0.16%	-0.46%	-0.33%
EPS (Basic)	3.48	3.96	4.58	4.53	4.05
EPS (Diluted)	3.48	3.96	4.57	4.52	4.04
EPS Growth	-12.06%	-13.41%	1.20%	11.88%	37.41%
Free Cash Flow	-	14.6	21.64	20.34	20.65
Free Cash Flow Per Share	-	4.17	5.95	5.58	5.64
Dividend Per Share	1.225	1.205	1.185	1.165	0.855
Dividend Growth	1.66%	1.69%	1.72%	36.26%	-23.66%
Gross Margin	57.12%	59.03%	59.81%	61.58%	63.03%
Operating Margin	29.60%	38.46%	36.71%	37.85%	38.49%
Profit Margin	29.30%	33.92%	33.12%	31.51%	30.15%
Free Cash Flow Margin	-	35.70%	43.09%	38.90%	42.10%
EBITDA	14.34	18.53	24.75	26.82	26.16
EBITDA Margin	37.24%	45.30%	49.28%	51.30%	53.33%
D&A For EBITDA	2.94	2.8	6.32	7.03	7.28
EBIT	11.4	15.73	18.44	19.79	18.88
EBIT Margin	29.60%	38.46%	36.71%	37.85%	38.49%
Effective Tax Rate	20.01%	17.43%	17.19%	20.26%	22.42%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q